| | | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
|---|
|
| juin 2021 - 115 Spécialités |
|
| L | | IPro | IPat | | Amlodipin/Valsartan
Viatris 5 mg/80 mg | 28 | 11.36 | 28.80 | 10% | | Comprimés filmés: 2 Principes actifs | Viatris Pharma GmbH | B / LS / SG | FB | | G |  |
| L | | IPro | IPat | | Amlodipin/Valsartan
Viatris 5 mg/80 mg | 98 | 36.71 | 56.40 | 10% | | Comprimés filmés: 2 Principes actifs | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| L | | IPro | | | Amlodipin/Valsartan
Vitatris 5 mg/160 mg | 28 | 13.48 | 31.10 | 10% | | Comprimés filmés: 2 Principes actifs | Viatris Pharma GmbH | ● B / LS / SG | FB | | G | |
| L | | IPro | | | Amlodipin/Valsartan
Vitatris 5 mg/160 mg | 98 | 47.13 | 67.70 | 10% | | Comprimés filmés: 2 Principes actifs | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| L | | IPro | | | Amlodipin/Valsartan
Viatris 10 mg/160 mg | 28 | 13.48 | 31.10 | 10% | | Comprimés filmés: 2 Principes actifs | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| L | | IPro | | | Amlodipin/Valsartan
Viatris 10 mg/160 mg | 98 | 47.13 | 67.70 | 10% | | Comprimés filmés: 2 Principes actifs | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| L | | IPro | IPat | | Fingolimod Spirig HC 0,5 mg | 28 | 380.52 | 430.25 | 10% | | Capsules: Fingolimodum | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| L | | IPro | IPat | | Fingolimod Spirig HC 0,5 mg | 98 | 1331.83 | 1464.85 | 10% | | Capsules: Fingolimodum | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | COLCTAB 0.5 mg | 30 | 16.70 | 34.60 | 10% | | Comprimés: Colchicinum | Streuli Pharma AG | A / LS | FB | | G | |
| L | | IPro | IPat | | COLCTAB 1 mg | 30 | 28.38 | 47.30 | 10% | | Comprimés: Colchicinum 1 mg | Streuli Pharma AG | A / LS | FB | | G | |
| | | IPro | IPat | | Bisoprolol NOBEL 2.5 mg | 200 | DDP | DDP | N.O. | | Comprimés filmés: Bisoprololi Fumaras 2.5 mg | NOBEL Pharma Schweiz AG | B | FB | | G | |
| | | IPro | | | Bisoprolol NOBEL 5 mg | 200 | DDP | DDP | N.O. | | Comprimés filmés: Bisoprololi Fumaras 5 mg | NOBEL Pharma Schweiz AG | B | FB | | G | |
| | | IPro | | | Bisoprolol NOBEL 10 mg | 200 | DDP | DDP | N.O. | | Comprimés filmés: Bisoprololi Fumaras 10 mg | NOBEL Pharma Schweiz AG | B | FB | | G | |
| | | IPro | | | Ezetimib Rosuvastatin
Spirig HC 10 mg / 5 mg | 30 | DDP | DDP | N.O. | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B | FB | | G | |
| | | IPro | | | Ezetimib Rosuvastatin
Spirig HC 10 mg / 5 mg | 100 | DDP | DDP | N.O. | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B | FB | | G | |
| | | IPro | IPat | | Fentalis 12 μg/h | 5 | 9.47 | 26.70 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 25 μg/h | 5 | 15.79 | 33.60 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 37.5 μg/h | 5 | 28.40 | 47.30 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 50 μg/h | 5 | 31.27 | 50.40 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 75 μg/h | 5 | 45.89 | 66.30 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 100 μg/h | 5 | 58.80 | 80.35 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | IPat | | Fentalis 12 μg/h | 10 | 17.19 | 35.10 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 25 μg/h | 10 | 27.66 | 46.50 | 10% | | | Sandoz
Pharmaceuticals AG | ● A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 37.5 μg/h | 10 | 51.56 | 72.50 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 50 μg/h | 10 | 56.76 | 78.15 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 75 μg/h | 10 | 80.57 | 104.05 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| | | IPro | | | Fentalis 100 μg/h | 10 | 103.47 | 128.95 | 10% | | | Sandoz
Pharmaceuticals AG | A+ / LS / SG | FB | | G | |
| L | | IPro | | | Azacitidin Ideogen 100 mg | | 189.00 | 223.75 | 10% | | Poudre et solvant pour suspension injectable: Azacitidinum 100 mg | Ideogen AG | A / LS / SG | FB | | G | |
| | | IPro | IPat | | Bisoprolol NOBEL 2.5 mg | 30 | 2.74 | 12.20 | 10% | | Comprimés filmés: Bisoprololi Fumaras 2.5 mg | NOBEL Pharma Schweiz AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Bisoprolol NOBEL 2.5 mg | 100 | 7.04 | 16.90 | 10% | | Comprimés filmés: Bisoprololi Fumaras 2.5 mg | NOBEL Pharma Schweiz AG | B / LS / SG | FB | | G | |
| | | IPro | | | Bisoprolol NOBEL 5 mg | 30 | 4.37 | 14.00 | 10% | | Comprimés filmés: Bisoprololi Fumaras 5 mg | NOBEL Pharma Schweiz AG | B / LS / SG | FB | | G | |
| | | IPro | | | Bisoprolol NOBEL 5 mg | 100 | 12.05 | 29.50 | 10% | | Comprimés filmés: Bisoprololi Fumaras 5 mg | NOBEL Pharma Schweiz AG | B / LS / SG | FB | | G | |
| | | IPro | | | Bisoprolol NOBEL 10 mg | 30 | 7.82 | 17.75 | 10% | | Comprimés filmés: Bisoprololi Fumaras 10 mg | NOBEL Pharma Schweiz AG | B / LS / SG | FB | | G | |
| | | IPro | | | Bisoprolol NOBEL 10 mg | 100 | 22.15 | 40.50 | 10% | | Comprimés filmés: Bisoprololi Fumaras 10 mg | NOBEL Pharma Schweiz AG | B / LS / SG | FB | | G | |
| L | | IPro | IPat | | Dasatinib Zentiva 20 mg | 60 | 484.40 | 543.25 | 10% | | Comprimés filmés: Dasatinibum 20 mg | Helvepharm AG | A / LS / SG | FB | | G | |
| L | | IPro | | | Dasatinib Zentiva 50 mg | 60 | 1072.75 | 1183.10 | 10% | | Comprimés filmés: Dasatinibum 50 mg | Helvepharm AG | ● A / LS / SG | FB | | G | |
| L | | IPro | | | Dasatinib Zentiva 70 mg | 60 | 1072.75 | 1183.10 | 10% | | Comprimés filmés: Dasatinibum 70 mg | Helvepharm AG | A / LS / SG | FB | | G | |
| L | | IPro | | | Dasatinib Zentiva 100 mg | 30 | 1102.52 | 1215.45 | 10% | | Comprimés filmés: Dasatinibum 100 mg | Helvepharm AG | A / LS / SG | FB | | G | |
| L | | IPro | IPat | | Lacosamid Sandoz 50 mg | 14 | 5.45 | 15.15 | 10% | | Comprimés filmés: Lacosamidum 50 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 100 mg | 14 | 10.77 | 28.15 | 10% | | Comprimés filmés: Lacosamidum 100 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 100 mg | 56 | 40.61 | 60.60 | 10% | | Comprimés filmés: Lacosamidum 100 mg | Sandoz
Pharmaceuticals AG | ● B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 100 mg | 168 | 118.62 | 145.40 | 10% | | Comprimés filmés: Lacosamidum 100 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 150 mg | 14 | 15.79 | 33.60 | 10% | | Comprimés filmés: Lacosamidum 150 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 150 mg | 56 | 59.98 | 81.65 | 10% | | Comprimés filmés: Lacosamidum 150 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 150 mg | 168 | 175.39 | 207.15 | 10% | | Comprimés filmés: Lacosamidum 150 mg | Sandoz
Pharmaceuticals AG | ● B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 200 mg | 14 | 21.04 | 39.30 | 10% | | Comprimés filmés: Lacosamidum 200 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 200 mg | 56 | 79.94 | 103.35 | 10% | | Comprimés filmés: Lacosamidum 200 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid Sandoz 200 mg | 168 | 233.86 | 270.75 | 10% | | Comprimés filmés: Lacosamidum 200 mg | Sandoz
Pharmaceuticals AG | ● B / LS / SG | FB | | G | |
| L | | IPro | IPat | | Lacosamid-Mepha 50 mg | 14 | 5.41 | 15.10 | 10% | | Comprimés filmés: Lacosamidum 50 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 100 mg | 14 | 10.76 | 28.10 | 10% | | Comprimés filmés: Lacosamidum 100 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 100 mg | 56 | 40.60 | 60.55 | 10% | | Comprimés filmés: Lacosamidum 100 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 100 mg | 168 | 118.57 | 145.35 | 10% | | Comprimés filmés: Lacosamidum 100 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 150 mg | 14 | 15.75 | 33.55 | 10% | | Comprimés filmés: Lacosamidum 150 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 150 mg | 56 | 59.96 | 81.65 | 10% | | Comprimés filmés: Lacosamidum 150 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 150 mg | 168 | 175.35 | 207.10 | 10% | | Comprimés filmés: Lacosamidum 150 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 200 mg | 14 | 21.02 | 39.30 | 10% | | Comprimés filmés: Lacosamidum 200 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 200 mg | 56 | 79.93 | 103.35 | 10% | | Comprimés filmés: Lacosamidum 200 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | | | Lacosamid-Mepha 200 mg | 168 | 233.83 | 270.70 | 10% | | Comprimés filmés: Lacosamidum 200 mg | Mepha Pharma AG | B / LS / SG | FB | | G | |
| L | | IPro | IPat | CM | Lenalidomid BMS 2,5 mg | 21 | 689.23 | 766.00 | 10% | | Capsules: Lenalidomidum 2.5 mg | Bristol-Myers Squibb SA | A / LS / SG | FB | | G | |
| L | | IPro | | CM | Lenalidomid BMS 5 mg | 21 | 707.76 | 786.15 | 10% | | Capsules: Lenalidomidum 5 mg | Bristol-Myers Squibb SA | A / LS / SG | FB | | G | |
| L | | IPro | | CM | Lenalidomid BMS 7,5 mg | 21 | 726.28 | 806.30 | 10% | | Capsules: Lenalidomidum 7.5 mg | Bristol-Myers Squibb SA | A / LS / SG | FB | | G | |
| L | | IPro | | CM | Lenalidomid BMS 10 mg | 21 | 744.81 | 826.45 | 10% | | Capsules: Lenalidomidum 10 mg | Bristol-Myers Squibb SA | A / LS / SG | FB | | G | |
| L | | IPro | | CM | Lenalidomid BMS 15 mg | 21 | 782.79 | 867.75 | 10% | | Capsules: Lenalidomidum 15 mg | Bristol-Myers Squibb SA | A / LS / SG | FB | | G | |
| L | | IPro | | CM | Lenalidomid BMS 20 mg | 21 | 821.96 | 910.35 | 10% | | Capsules: Lenalidomidum 20 mg | Bristol-Myers Squibb SA | A / LS / SG | FB | | G | |
| L | | IPro | | CM | Lenalidomid BMS 25 mg | 21 | 861.14 | 952.95 | 10% | | Capsules: Lenalidomidum 25 mg | Bristol-Myers Squibb SA | A / LS / SG | FB | | G | |
| L | | IPro | IPat | | Veblocema 120 mg | | 532.11 | 592.00 | 10% | | Solution injectable en seringue prête à l'emploi: Infliximabum 120 mg/ml | iQone Healthcare
Switzerland SA | A / LS | FB | | G | |
| L | | IPro | | | Oyavas 100 mg/4 ml | | 257.57 | 296.55 | 10% | | Concentré pour perfusion: Bevacizumabum 100mg / 4ml | Spirig HealthCare AG | A / LS | FB | | G | |
| L | | IPro | | | Oyavas 400 mg/16 ml | | 962.84 | 1063.55 | 10% | | Concentré pour perfusion: Bevacizumabum 400mg / 16ml | Spirig HealthCare AG | A / LS | FB | | G | |
| L | | IPro | | | Ezetimib Rosuvastatin
Spirig HC 10 mg / 20 mg | 30 | 28.83 | 47.75 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS | FB | | G | |
| L | | IPro | | | Ezetimib Rosuvastatin
Spirig HC 10 mg / 20 mg | 100 | 96.11 | 120.95 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS | FB | | G | |
| L | | IPro | IPat | | Ezetimib Rosuvastatin
Spirig HC 10 mg / 10 mg | 30 | 25.05 | 43.65 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | ● B / LS | FB | | G | |
| L | | IPro | IPat | | Ezetimib Rosuvastatin
Spirig HC 10 mg / 10 mg | 100 | 83.50 | 107.25 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS | FB | | G | |
| L | | IPro | IPat | | Tepmetko 225 mg | 60 | 5981.89 | 6445.20 | 10% | | Comprimés filmés: Tepotinibum 225 mg | Merck (Schweiz) AG | A / LS | FB | | G | |
| | | IPro | IPat | | COLCTAB 1 mg | 10 | 11.13 | 28.50 | 10% | | Comprimés: Colchicinum 1 mg | Streuli Pharma AG | A / LS | FB | | G | |
| L | | IPro | | | Polivy 30 mg | | 1974.73 | 2164.05 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Polatuzumabum Vedotinum 30 mg | Roche Pharma
(Schweiz) AG | A / LS | FB | | G | |
| L | | IPro | | | Polivy 140 mg | | 9215.41 | 9762.80 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Polatuzumabum Vedotinum 140 mg | Roche Pharma
(Schweiz) AG | A / LS | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 3 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 3 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 2 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 4 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 4 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 3 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 5 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 5 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 6 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 6 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 4 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 7 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 7 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 5 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 8 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 8 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 9 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 9 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 6 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 10 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 10 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 7 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 11 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 11 x 5.5 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 8 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 9 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | ZOLGENSMA | 10 x 8.3 ml | DDP | DDP | N.O. | | Onasemnogenum Abeparvovecum 2 | Novartis Pharma
Schweiz AG | A | FB | | G | |
| | | IPro | IPat | | Softacort 3,35 mg/ml | 10 | DDP | DDP | N.O. | | Collyre: Hydrocortisoni Phosphas Natricus 3.35 mg/ml | THEA Pharma S.A. | B | FB | | G | |
| | | IPro | IPat | | Softacort 3,35 mg/ml | 20 | DDP | DDP | N.O. | | Collyre: Hydrocortisoni Phosphas Natricus 3.35 mg/ml | THEA Pharma S.A. | B | FB | | G | |
| | | IPro | IPat | | Softacort 3,35 mg/ml | 30 | DDP | DDP | N.O. | | Collyre: Hydrocortisoni Phosphas Natricus 3.35 mg/ml | THEA Pharma S.A. | B | FB | | G | |
| | | IPro | IPat | | Softacort 3,35 mg/ml | 60 | DDP | DDP | N.O. | | Collyre: Hydrocortisoni Phosphas Natricus 3.35 mg/ml | THEA Pharma S.A. | B | FB | | G | |
| | | IPro | | | Foscarnet Ideogen 24
mg/ml | | DDP | DDP | N.O. | | Solution pour perfusion: Foscarnetum Natricum Hexahydricum 24 mg/ml | Ideogen AG | A | FB | | G | |
| | | IPro | IPat | | Veblocema 120 mg | 2 | DDP | DDP | N.O. | | Solution injectable en seringue prête à l'emploi: Infliximabum 120 mg/ml | iQone Healthcare
Switzerland SA | A | FB | | G | |
| | | IPro | IPat | | Veblocema 120 mg | 4 | DDP | DDP | N.O. | | Solution injectable en seringue prête à l'emploi: Infliximabum 120 mg/ml | iQone Healthcare
Switzerland SA | A | FB | | G | |
| | | IPro | IPat | CM | Coop Vitality Glycolax | 18 | DDP | DDP | N.O. | | Suppositoires: Glycerolum 2250 mg | Coop Vitality Health
Care GmbH | D | FB | | G | |
| | | IPro | IPat | CM | SUN STORE Glycolax | 18 | DDP | DDP | N.O. | | Suppositoires: Glycerolum 2250 mg | Sun Store Health Care AG | D | FB | | G | |
| | | IPro | IPat | | Xarelto junior | | DDP | DDP | N.O. | | Granulat zur Herstellung einer Suspension zum Einnehmen: Rivaroxabanum 1 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | IPat | | Xarelto junior | | DDP | DDP | N.O. | | Granulat zur Herstellung einer Suspension zum Einnehmen: Rivaroxabanum 1 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | | | IPat | | Gemmo Magenbeschwerden | 30 ml | DDP | DDP | N.O. | | Spray zur Anwendung in der Mundhöhle: Ficus Carica e Gemma Recenti D1 (Ph.Eur.Hom. 2.1.3) 1 ml | Spagyros AG | D | FB | | G | |
